https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

CABG

Showing all 5 results

Cardiac Surgery Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 15 more

The global market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter mitral valve repair (TMVr) devices, transcatheter aortic heart valve implantation (TAVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, autotransfusion (AD) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), ventricular assist devices (VADs), intra-aortic balloon pump (IABP) devices, patent foramen ovale (PFO) devices, atrial and ventricular septal defect (ASD and VSD) devices, left atrial appendage closure (LAA) devices, preshaped guidewires and cerebral embolic protection devices.

more...

On-Pump and Off-Pump Coronary Artery Bypass Device Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: ONCAB Disposables Market, Perfusion System Market, Stabilizer Device Market, Positioner Device Market

Off-pump coronary artery bypass (OPCAB), or simply beating-heart coronary artery bypass grafting, uses a median sternotomy to access the heart, similar to on-pump coronary artery bypass (ONCAB) procedures. The important difference is that the cardiopulmonary bypass pump is not employed. Clinical studies show that OPCAB offers several benefits compared to ONCAB procedures, including reductions in bleeding, short-term neurocognitive dysfunction, kidney dysfunction and length of hospital stay.

more...

Cardiac Surgery Procedure Volume Analysis | Global | 2021-2027 | MedPro | Segmented by: Material, Indication, Type, and More

Globally, over 6 million cardiac surgery procedures were performed in 2020. The majority of these procedures were autotransfusion procedures followed by surgical heart valve procedures. Over the forecast period, all of the procedures included in this report are projected to experience growth, some faster than others, following COVID-19 headwinds. 

more...

Cardiac Surgery Market Size, Share, and COVID-19 Impact Analysis | United States | 2020-2026 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 21 more

In 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies

more...

Cardiac Surgery Market Size, Share, and COVID-19 Impact Analysis | Europe | 2020-2026 | MedSuite | Includes: Tissue Heart Valve Market, TAVI/TAVR Market, and 21 more

In 2020, the European cardiac surgery device market size was valued at €2.6 billion, with over 50,000 Transcatheter Aortic Valve Implantation (TAVI) procedures performed. Despite COVID19, the market size is expected to reach an insane €5.6 billion in 2026. Throughout this medical market research, we analyzed 40 cardiac surgery companies across 15 countries in Europe

more...